After Brief Halt, F.D.A. Allows Sales of Drug for Cancer to Resume
Saturday, December 21, 2013 - 01:50
in Health & Medicine
The Food and Drug Administration, which halted the sale of Iclusig because of potentially deadly side effects, said the drug could again be marketed, though for a somewhat smaller patient population.